Highlights for Monday, May 23

2016-05-23
Below are the 3 articles selected as suggested reading for this week by McMaster editors.
Please be advised that until the end of August Publications of the Week will be temporarily published in a less frequent, biweekly cycle.

Timing of RRT in ICU patients

Gaudry S, Hajage D, Schortgen F, et al; AKIKI Study Group. Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit. N Engl J Med. 2016 May 15. [Epub ahead of print] PubMed PMID: 27181456.
Mehta RL. Renal-Replacement Therapy in the Critically Ill - Does Timing Matter? N Engl J Med. 2016 May 15. [Epub ahead of print] PubMed PMID: 27181293.

This study investigated the potential effects of an early start of dialysis therapy in critically ill patients with new onset of acute renal failure. The authors found no significant advantages of starting dialysis early versus dialyzing only once a definitive indication for dialysis occurred. Such criteria included a blood urea nitrogen (BUN) level over 40 mmol/L, acidosis (pH <7.15), a potassium level over 6 mmol/L, oliguria or anuria for more than 72 hours, acidosis, and acute pulmonary edema. While there was no difference in mortality, 50% of patients in the delayed-dialysis group avoided dialysis.

These results will likely help in situations of management uncertainty and apply to many intensive care unit patients who have acute kidney injury yet still do not require immediate dialysis.

LAMA vs ICS in patients with COPD

Wedzicha JA, Banerji D, Chapman KR, et al; FLAME Investigators. Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD. N Engl J Med. 2016 May 15. [Epub ahead of print] PubMed PMID: 27181606.

Among patients at high risk of chronic obstructive pulmonary disease (COPD) exacerbations, a combination of a long-acting ß2-agonists (LABA) and a long-acting muscarinic antagonist (LAMA) was associated with less frequent exacerbations than the often recommended combination of a LABA and an inhaled corticosteroid (ICS) (3.59 vs 4.03 exacerbations per year). Patients included in this study had COPD of at least moderate severity (grade 2 or higher on the 4-point modified Medical Research Council scale), FEV1 from 25% to 60% less than predicted, FEV1/FVC less than 70%, and at least 1 COPD exacerbation treated with antibiotics, steroids, or both within the previous year.

Bariatric surgery in adolescents

Inge TH, Courcoulas AP, Jenkins TM, et al; Teen-LABS Consortium. Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents. N Engl J Med. 2016 Jan 14;374(2):113-23. doi: 10.1056/NEJMoa1506699. Epub 2015 Nov 6. PubMed PMID: 26544725; PubMed Central PMCID: PMC4810437.

Bariatric surgery performed on over 200 adolescents aged 13 to 19 years was associated with a major weight loss (from a body mass index of 53 to 38; percentage change: 28% for gastric bypass and 26% for sleeve gastrectomy). Among patients who had such conditions at baseline, resolution of diabetes mellitus (13%) and prediabetes (10%) occurred at 3 years in over 90% and 75% of patients, respectively; resolution of hypertension (prevalence, 43%) in over 75% of patients; and resolution of hyperlipidemia (prevalence, 76%) in over two-thirds of all patients. About 13% of patients required another surgery within the next 3 years (majority cholecystectomy) and 5% required endoscopic stricture dilation.

These results may help people considering such surgery in young patients.

See also

We would love to hear from you

Comments, mistakes, suggestions?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.